Cargando…

Insulin-like growth factor 1/Child-Turcotte-Pugh composite score as a predictor of treatment outcomes in patients with advanced hepatocellular carcinoma treated with sorafenib

Background: Sorafenib was the first systemic therapy approved for the treatment of Child-Turcotte-Pugh (CTP) class A patients with advanced hepatocellular carcinoma (HCC). However, there are no biomarkers to predict survival and treatment outcomes and guide HCC systemic therapy. Type 1 insulin-like...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohamed, Yehia I., Lee, Sunyoung, Xiao, Lianchun, Hassan, Manal M., Qayyum, Aliya, Hiatia, Rikita, Pestana, Roberto Carmagnani, Haque, Abedul, George, Bhawana, Rashid, Asif, Duda, Dan G., Elghazaly, Hesham, Wolff, Robert A., Morris, Jeffrey S., Yao, James, Amin, Hesham M., Kaseb, Ahmed O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057275/ https://www.ncbi.nlm.nih.gov/pubmed/33889299 http://dx.doi.org/10.18632/oncotarget.27924

Ejemplares similares

Blockade of growth hormone receptor signaling by using pegvisomant: A functional therapeutic strategy in hepatocellular carcinoma
por: Kaseb, Ahmed O., et al.
Publicado: (2022)

Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced hepatocellular carcinoma patients
por: Mohamed, Yehia I., et al.
Publicado: (2022)

Disruption of Growth Hormone Receptor Signaling Abrogates Hepatocellular Carcinoma Development
por: Haque, Abedul, et al.
Publicado: (2022)

Prognostic Significance of Serum Insulin-Like Growth Factor-1 in Hepatocellular Cancer Patients: A Validation Study
por: Lacin, Sahin, et al.
Publicado: (2020)

Origin and role of hepatic myofibroblasts in hepatocellular carcinoma
por: Yavuz, Betul Gok, et al.
Publicado: (2020)

Community-Metabolome Correlations of Gut Microbiota from Child-Turcotte-Pugh of A and B Patients
por: Wei, Xiao, et al.
Publicado: (2016)

Recalibrating the Child–Turcotte–Pugh Score to Improve Prediction of Transplant-Free Survival in Patients with Cirrhosis
por: Kaplan, David E., et al.
Publicado: (2016)

Does adding variceal status to the Child–Turcotte–Pugh score improve its performance in predicting mortality in cirrhosis?
por: Fan, Xiaoli, et al.
Publicado: (2016)

Predictive power of Model for End-Stage Liver Disease and Child-Turcotte-Pugh score for mortality in cirrhotic patients
por: Piotrowski, Damian, et al.
Publicado: (2018)

A modified Child-Turcotte-Pugh score based on plasma ammonia predicts survival for patients with decompensated cirrhosis
por: Wang, X, et al.
Publicado: (2023)

Albumin - bilirubin (ALBI) versus Child-Turcotte-Pugh (CTP) in prognosis of HCC after stereotactic body radiation therapy
por: Su, Ting-Shi, et al.
Publicado: (2019)

Assessment of frailty in cirrhosis using bedside measures and its correlation with Child-Turcotte-Pugh, MELD & MELD-Na Scores
por: Zuberi, Bader Faiyaz, et al.
Publicado: (2022)

Clinical and prognostic significance of circulating levels of angiopoietin-1 and angiopoietin-2 in hepatocellular carcinoma
por: Pestana, Roberto Carmagnani, et al.
Publicado: (2018)

Serum Ferritin Levels: A Potential Biomarker to Represent Child-Turcotte-Pugh Score among Decompensated Liver Cirrhosis Patients
por: Sungkar, Taufik, et al.
Publicado: (2019)

Study of Gonadal Hormones in Males With Liver Cirrhosis and Its Correlation With Child-Turcotte-Pugh and Model for End-Stage Liver Disease Scores
por: Vaishnav, Bhumika, et al.
Publicado: (2023)

Immunotherapy response evaluation with magnetic resonance elastography (MRE) in advanced HCC
por: Qayyum, Aliya, et al.
Publicado: (2019)

Clinical and Prognostic Biomarker Value of Blood-Circulating Inflammatory Cytokines in Hepatocellular Carcinoma
por: Chamseddine, Shadi, et al.
Publicado: (2023)

A New Child-Turcotte-Pugh Class 0 for Patients with Hepatocellular Carcinoma: Determinants, Prognostic Impact and Ability to Improve the Current Staging Systems
por: Lee, Yun-Hsuan, et al.
Publicado: (2014)

Dual inhibition of IGF-IR and ALK as an effective strategy to eradicate NPM-ALK(+) T-cell lymphoma
por: George, Bhawana, et al.
Publicado: (2019)

Correction: Dual inhibition of IGF-IR and ALK as an effective strategy to eradicate NPM-ALK(+) T-cell lymphoma
por: George, Bhawana, et al.
Publicado: (2023)

Validation of a Modified Child-Turcotte-Pugh Classification System Utilizing Insulin-Like Growth Factor-1 for Patients with Hepatocellular Carcinoma in an HBV Endemic Area
por: Lee, Dong Hyeon, et al.
Publicado: (2017)

Tribute to Fernand Turcotte, former editor with the CJPH
por: Rochon, Jean
Publicado: (2020)

Comparison of the Child-Turcotte-Pugh Classification and the Model for End-stage Liver Disease Score as Predictors of the Severity of the Systemic Inflammatory Response in Patients Undergoing Living-donor Liver Transplantation
por: Hong, Sang-Hyun, et al.
Publicado: (2011)

Intravoxel Incoherent Motion (IVIM) Diffusion-Weighted Imaging (DWI) in Patients with Liver Dysfunction of Chronic Viral Hepatitis: Segmental Heterogeneity and Relationship with Child-Turcotte-Pugh Class at 3 Tesla
por: Ding, Lei, et al.
Publicado: (2018)

Correlation of Model for End Stage Liver Disease (MELD), MELD-Sodium (MELD-Na), and Child-Turcotte-Pugh (CTP) Score With Frailty in Patients With Hepatitis C Virus (HCV) Related Cirrhosis
por: Panezai, Muhammad Qaiser, et al.
Publicado: (2023)

A Prospective Phase II Study of Safety and Efficacy of Sorafenib Followed by (90)Y Glass Microspheres for Patients with Advanced or Metastatic Hepatocellular Carcinoma
por: Kaseb, Ahmed Omar, et al.
Publicado: (2021)

Percentage of small platelets on peripheral blood smear and Child-Turcott-Pugh class can predict the presence of oesophageal varices in newly diagnosed patients with cirrhosis: development of a prediction model for resource limited settings
por: Perera, K., et al.
Publicado: (2019)

Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma and Child-Pugh A or B cirrhosis
por: FEDERICO, ALESSANDRO, et al.
Publicado: (2015)

Validation of an IGF-CTP scoring system for assessing hepatic reserve in egyptian patients with hepatocellular carcinoma
por: Abdel-Wahab, Reham, et al.
Publicado: (2015)

The Model for End-Stage Liver Disease Score-Based System Predicts Short Term Mortality Better Than the Current Child-Turcotte-Pugh Score-Based Allocation System during Waiting for Deceased Liver Transplantation
por: Hong, Geun, et al.
Publicado: (2013)

Comparison of nivolumab and sorafenib for first systemic therapy in patients with hepatocellular carcinoma and Child‐Pugh B cirrhosis
por: Chapin, William J., et al.
Publicado: (2022)

Sorafenib for Patients with Hepatocellular Carcinoma and Child‐Pugh B Liver Cirrhosis: Lessons Learned from a Terminated Study
por: Labeur, Tim A., et al.
Publicado: (2019)

Child–Pugh Score and ABCG2-rs2231142 Genotype Independently Predict Survival in Advanced Hepatoma Patients Treated with Sorafenib
por: Huang, Po-Han, et al.
Publicado: (2022)

The Gut Microbiome as a Biomarker and Therapeutic Target in Hepatocellular Carcinoma
por: Gok Yavuz, Betul, et al.
Publicado: (2023)

Analysis of histology-agnostic targets among soft tissue and bone sarcomas in the AACR GENIE database
por: Pestana, Roberto Carmagnani, et al.
Publicado: (2023)

Comparison between Child-Pugh Score and albumin-bilirubin grade in patients treated with the combination therapy of transarterial chemoembolization and sorafenib for hepatocellular carcinoma
por: Wang, Zhexuan, et al.
Publicado: (2020)

Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinoma
por: Kaseb, Ahmed Omar, et al.
Publicado: (2016)

Therapeutic effects of regorafenib after sorafenib monotherapy with advanced hepatocellular carcinoma including Child–Pugh classification B: A retrospective observational study
por: Komiyama, Satoshi, et al.
Publicado: (2020)

Introducing Edward N. Pugh, Jr.
por: Sparre Andersen, Olaf
Publicado: (2008)

Sofosbuvir/velpatasvir plus ribavirin for Child-Pugh B and Child-Pugh C hepatitis C virus-related cirrhosis
por: Liu, Chen-Hua, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mookg7hqhr2qh0se4jr220d0pg